Details of the Drug Reposition

General Information of This Drug (ID: DM0TD4G)

Drug Name
NanoPac   DM0TD4G

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Ovarian cancer DISZJHAP 2C73 Phase 2 [1]
Prostate cancer DISF190Y 2C82.0 Phase 2 [1]
Skin metastasis DISPEIJ9 2D50 Phase 2 [2]
Actinic keratosis DISR1RC5 EK90.0 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)